All-trans retinoic acid (ATRA) and IFN-β can induce up-regulation of CD38 in tumor cells, and CD38 inhibits CD8+ T cell function through adenosine receptor signaling, thereby making tumor resistant to PD-L1/PD-1 blockade. This evidence concerns the gene CD38 and neoplasm.